Travere Therapeutics, Inc. · NASDAQ:TVTX

Armistice Capital, LLC reported a 5.27% stake in Travere Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Armistice Capital, LLC reported a 5.27% stake in Travere Therapeutics, Inc., 4,897,417 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
5.27%
Shares
4,897,417
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC5.27%4,897,417
Steven Boyd5.27%4,897,417

Source

View original at SEC

Related